Items where Author is "Valverde Mordt, O."

2023

Mesu, V. K. B. K. and Kalonji, W. M. and Rembry, S. and Valverde Mordt, O. and Ngolo Tete, D. and Prêtre, A. and Delhomme, S. and Ilunga Wa Kyhi, M. and Camara, M. and Catusse, J. and Schneitter, S. and Nusbaumer, M. and Mwamba Miaka, E. and Mahenzi Mbembo, H. and Makaya Mayawula, J. and Layba Camara, M. and Akwaso Massa, F. and Kaninda Badibabi, L. and Kasongo Bonama, A. and Kavunga Lukula, P. and Mutanda Kalonji, S. and Mariero Philemon, P. and Mokilifi Nganyonyi, R. and Embana Mankiara, H. and Asuka Akongo Nguba, A. and Kobo Muanza, V. and Mulenge Nasandhel, E. and Fifi Nzeza Bambuwu, A. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2023) Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. The Lancet infectious diseases, 23 (4). pp. 463-470.

2022

Kande Betu Kumesu, V. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Nganzobo Ngima, P. and Mahenzi Mbembo, H. and Fina Lubaki, J. P. and Lumeya Vuvu, S. and Kuziena Mindele, W. and Ilunga Wa Kyhi, M. and Mandula Mokenge, G. and Kaninda Badibabi, L. and Kasongo Bonama, A. and Kavunga Lukula, P. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2022) Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial. Lancet Glob Health, 10 (11). e1665-e1674.

2021

Kümmerle, A. and Schmid, C. and Bernhard, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. N. and Kisala, M. and Burri, C. and Blesson, S. and Valverde Mordt, O.. (2021) Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis, 15 (11). e0009903.

Mesu, V. K. B. K. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Mahenzi Mbembo, H. and Mpia Moke, C. and Lumeya Vuvu, S. and Mudji E'kitiak, J. and Akwaso Masa, F. and Mukendi Ilunga, M. and Mpoyi Muamba Nzambi, D. and Mayala Malu, T. and Kapongo Tshilumbwa, S. and Botalema Bolengi, F. and Nkieri Matsho, M. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2021) Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Lancet Glob Health, 9 (7). e999-e1008.